Page last updated: 2024-12-05

terephthalic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Terephthalic acid is a white, crystalline solid with the formula C8H6O4. It is a dicarboxylic acid, meaning it has two carboxyl groups (-COOH). Terephthalic acid is an important industrial chemical, used primarily in the production of polyethylene terephthalate (PET), a polyester that is used to make plastic bottles, clothing, and other products. It is also used in the production of other polymers, such as polybutylene terephthalate (PBT) and polytrimethylene terephthalate (PTT). Terephthalic acid is synthesized by the oxidation of p-xylene with oxygen in the presence of a catalyst. The reaction is typically carried out at high temperatures and pressures. Terephthalic acid is a relatively stable compound, but it can be degraded by strong acids and bases. It is also susceptible to oxidation by strong oxidizing agents. Terephthalic acid is not known to have any significant health effects, but it should be handled with care. '

terephthalic acid: RN given refers to 1,4-benzenedicarboxylic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

terephthalic acid : A benzenedicarboxylic acid carrying carboxy groups at positions 1 and 4. One of three possible isomers of benzenedicarboxylic acid, the others being phthalic and isophthalic acids. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7489
CHEMBL ID1374420
CHEBI ID15702
SCHEMBL ID1655
MeSH IDM0057615

Synonyms (92)

Synonym
BIDD:ER0245
benzene-1,4-dicarboxylic acid
para-benzenedicarboxylic acid
CHEBI:15702 ,
acide terephtalique
p-dicarboxybenzene
p-phthalic acid
nsc36973
kyselina terftalova
wr 16262
p-benzenedicarboxylic acid
benzene-p-dicarboxylic acid
wln: qvr dvq
nsc-36973
ta 12
NCGC00091618-01
brn 1909333
einecs 202-830-0
p-carboxybenzoic acid
hsdb 834
kyselina tereftalova [czech]
para-phthalic acid
nsc 36973
tephthol
ta-33mp
ccris 2786
ai3-16108
acide terephtalique [french]
1,4-benzenedicarboxylic acid
terephthalic acid
C06337
100-21-0
terephthalic acid, 98%
NCGC00091618-02
1,4-dicarboxybenzene
T0166
AKOS000119464
NCGC00091618-03
unii-6s7nkz40bq
kyselina tereftalova
ec 202-830-0
6s7nkz40bq ,
4-09-00-03301 (beilstein handbook reference)
cas-100-21-0
NCGC00257014-01
dtxsid6026080 ,
tox21_303229
dtxcid006080
NCGC00259208-01
tox21_201659
terephthalsäure
STL281856
FT-0674866
CHEMBL1374420
4-carboxybenzoic acid
AE-562/40217759
S6251
BP-21157
SCHEMBL1655
terephthalic acid [mi]
terephthalic acid [hsdb]
terephtalic acid
benzene-1,4-dioic acid
p-phthalate
benzene, p-dicarboxylic acid
benzene, 1,4-dicarboxylic acid
AC-10250
terephthalic-carboxy-13c2 acid
mfcd00002558
terephthalic acid, saj special grade, >=98.0%
terephthalic acid, analytical standard
p-benzenedicarboxylate
p-phthelate
p-phthelic acid
benzene-p-dicarboxylate
'benzene-1,4-dicarboxylic acid'
UB7 ,
terephthalic acid, 97%
terephthalic acid, vetec(tm) reagent grade, 98%
Z57127536
CS-W010814
HY-W010098
BCP06429
Q408984
FT-0773240
STR02759
EN300-18042
A852800
p-pthalic acid
purified terephthalic acid
p-dicarboxybenzoic acid
1,4-benzene dicarboxylic acid

Research Excerpts

Overview

Terephthalic acid (TPA) is a worldwide aromatic compound widely used to manufacture resins. It is the raw material for the polymerization reaction with ethylene glycol to produce polyethylene terephthalate, known as PET. TerephthalIC acid is a main component in alkali-decrement wastewater.

ExcerptReferenceRelevance
"Terephthalic acid (TPA) is an important commodity chemical used as a monomer of polyethylene terephthalate (PET). "( Improved terephthalic acid production from p-xylene using metabolically engineered Pseudomonas putida.
Choi, KR; Lee, SY; Luo, ZW, 2023
)
2.77
"Terephthalic acid (TPA) is a worldwide aromatic compound widely used to manufacture resins and the raw material for the polymerization reaction with ethylene glycol to produce polyethylene terephthalate, known as PET. "( Testicular toxicity in mice exposed to terephthalic acid in utero and during lactation.
Amaral, EA; Auharek, SA; Cunha-Laura, AL; Monteiro, DS; Monteiro, GN; Oliveira, RJ, 2023
)
2.62
"Terephthalic acid (TPA) is an important industrial chemical currently produced by energy intensive and potentially hazardous p-xylene (pX) oxidation process. "( Biotransformation of p-xylene into terephthalic acid by engineered Escherichia coli.
Lee, SY; Luo, ZW, 2017
)
2.17
"Terephthalic acid, which is a main component in alkali-decrement wastewater, is efficiently removed using ferric chloride in high pH solutions. "( Removal of terephthalic acid in alkalized wastewater by ferric chloride.
Lin, J; Lv, JZ; Tong, SP; Wang, LL; Wen, YZ; Zheng, KF, 2006
)
2.17

Treatment

ExcerptReferenceRelevance
"Untreated terephthalic acid (TPA) wastewaters with high organic loads will cause severe environmental pollution problems. "( Performance evaluation of a lab-scale moving bed biofilm reactor (MBBR) using polyethylene as support material in the treatment of wastewater contaminated with terephthalic acid.
Dong, W; Fang, Y; He, A; Jiang, M; Liu, J; Liu, S; Ma, J; Xin, F; Xu, N; Zhang, W; Zhou, J, 2019
)
1.11

Toxicity

ExcerptReferenceRelevance
" The Panel concluded that modified terephthalate polymers were safe as cosmetic ingredients in the practices of use and concentration described in this safety assessment."( Safety assessment of modified terephthalate polymers as used in cosmetics.
Andersen, FA; Becker, LC; Belsito, DV; Bergfeld, WF; Hill, RA; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.13
" Of the isomers examined, PA appeared to be the most toxic and may serve as a surrogate biomarker for reproductive toxicity following mixed exposure to phthalates."( Comparative Cytotoxicity and Sperm Motility Using a Computer-Aided Sperm Analysis System (CASA) for Isomers of Phthalic Acid, a Common Final Metabolite of Phthalates.
Kwack, SJ; Lee, BM, 2015
)
0.42
" This work first evaluated the LD50 of different size of nPET (200 nm, S-nPET; 700 nm, B-nPET) in mice, then studied the health effects of single exposure to S/B-nPET at 200 mg/kg bw for 30 days."( The toxicity of nano polyethylene terephthalate to mice: Intestinal obstruction, growth retardant, gut microbiota dysbiosis and lipid metabolism disorders.
An, L; Cui, L; Li, B; Li, YF; Lin, X; Shi, N; Tian, X; Wang, J; Wang, L; Xie, H; Zhang, Y; Zhao, J, 2023
)
0.91
" It was showed that nPET, at 10 mg/L, was more toxic to rice seedlings, inhibiting growth and impairing chlorophyll content, MDA content, and SOD activity compared to mPET."( Screening the phytotoxicity of micro/nanoplastics through non-targeted metallomics with synchrotron radiation X-ray fluorescence and deep learning: Taking micro/nano polyethylene terephthalate as an example.
Chen, D; Chen, R; Cui, L; Li, B; Li, YF; Wang, L; Wang, W; Wei, C; Xie, H; Yu, YL, 2024
)
1.44

Pharmacokinetics

ExcerptReferenceRelevance
" After iv injection, the plasma concentration-time data were fitted using a three-compartment pharmacokinetic model."( Chemical urolithiasis. III. Pharmacokinetics and transplacental transport of terephthalic acid in Fischer-344 rats.
Chin, TY; d'A Heck, H; Wolkowski-Tyl, R,
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
"A comparison was performed on various methods detecting the volatile contaminants (VCs) in recycled poly(ethylene terephthalate) (rPET) flakes, the results demonstrated that head-space solid phase micro-extraction combined with comprehensive two-dimensional gas chromatograph-tandem quadrupole-time-of-flight mass spectrometry (HS-SPME-GC×GC-QTOF-MS) was a sensitive, effective, accurate method, and successfully applied to analyze 57 rPET flakes collected from different recycling plants in China."( Occurrence of volatile contaminants in recycled poly(ethylene terephthalate) by HS-SPME-GC×GC-QTOF-MS combined with chemometrics for authenticity assessment of geographical recycling regions.
Chen, S; Dong, B; Li, D; Li, H; Lin, Q; Su, QZ; Wu, S; Wu, X; Zheng, J; Zhong, HN; Zhu, L, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" TPA is well absorbed when given orally and rapidly eliminated via urine."( [Toxicokinetics of terephthalic acid].
Dai, J; Wang, D; Wang, X; Yao, H, 2001
)
0.64
" Under the alternating magnetic field (AMF), the specific absorption rate (66."( A novel biocompatible core-shell magnetic nanocomposite based on cross-linked chitosan hydrogels for in vitro hyperthermia of cancer therapy.
Asgharnasl, S; Eivazzadeh-Keihan, R; Hajizadeh, Z; Maleki, A; Radinekiyan, F; Salimi Bani, M, 2019
)
0.51
"Microplastics (MPs) that enter the soil can alter the physicochemical and biochemical properties of soil and affect speciation of heavy metals (HMs), thereby perturbing the bioavailability of HMs."( Polyethylene and poly (butyleneadipate-co-terephthalate)-based biodegradable microplastics modulate the bioavailability and speciation of Cd and As in soil: Insights into transformation mechanisms.
Chen, B; Gao, Q; He, S; Li, C; Li, Y; Shi, Y; Sun, H; Zhang, X; Zhang, Z; Zhao, P; Zhao, Z, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves for the induction of urolithiasis in weanling rats were extremely steep, consistent with the fact that the formation calculi can occur in urine that is supersaturated, but not in urine that is undersaturated with respect to the stone components."( The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment.
Heck, HD; Tyl, RW, 1985
)
0.55
" The increasing ferric chloride dosage had a dramatic positive impact on the achieved removal of terephthalic acid."( Removal of terephthalic acid in alkalized wastewater by ferric chloride.
Lin, J; Lv, JZ; Tong, SP; Wang, LL; Wen, YZ; Zheng, KF, 2006
)
0.94
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenedicarboxylic acidA member of the class of benzoic acids in that consists of benzene substituted by two carboxy groups (A closed class).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency50.11870.000221.22318,912.5098AID588516
thyroid stimulating hormone receptorHomo sapiens (human)Potency25.11890.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.28910.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency24.35220.000817.505159.3239AID1159527
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.51780.000229.305416,493.5996AID743069
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency21.87510.057821.109761.2679AID1159526
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency0.00500.316212.443531.6228AID924
Integrin beta-3Homo sapiens (human)Potency0.00500.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency0.00500.316211.415731.6228AID924
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (70)

Processvia Protein(s)Taxonomy
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (30)

Processvia Protein(s)Taxonomy
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1235354Antifungal activity against Cochliobolus lunatus strain MUCL 38696 at 100 uM by growth based assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies.
AID631930Dissociation constant, pKa of the compound2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID631927Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID631928Ratio of caffeic acid IC50 to compound IC50 for antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID631929Ratio of benzoic acid IC50 to compound IC50 for antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (498)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (2.21)18.7374
1990's22 (4.42)18.2507
2000's114 (22.89)29.6817
2010's173 (34.74)24.3611
2020's178 (35.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 108.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index108.27 (24.57)
Research Supply Index6.25 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index197.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (108.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.19%)5.53%
Reviews15 (2.91%)6.00%
Case Studies1 (0.19%)4.05%
Observational0 (0.00%)0.25%
Other498 (96.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of a Vertebral Body Tethering Technique for Pediatric Idiopathic Scoliosis [NCT04119284]30 participants (Anticipated)Interventional2019-09-01Suspended(stopped due to IRB suspended the study.)
Transdermal Microneedle Patch To Enhance Topical Anaesthesia Before Intravenous Line Insertion for Blood Transfusion In Paediatric Thalassemia Patients [NCT05078463]Phase 220 participants (Actual)Interventional2021-09-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]